Elfabrio® (pegunigalsidase alfa-iwxj)
| Full Name | Elfabrio® (pegunigalsidase alfa-iwxj) |
| Drug | Elfabrio |
| Manufacturer | Chiesi |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of adults with confirmed Fabry disease |
| Disease | Fabry disease |
| Therapeutic Area | Neurology, Nephrology, Genetics |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 833-656-1056 |
| Fax Number | 636-355-3610 |
| Product Website | hcp.elfabrio.com |